Linked Data API

Show Search Form

Search Results

1134462
registered interest false more like this
date less than 2019-06-25more like thismore than 2019-06-25
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care remove filter
hansard heading Alcoholic Drinks: Scotland more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the effect of the introduction of minimum unit pricing of alcohol in Scotland on the level of alcohol consumption in Scotland. more like this
tabling member constituency Coatbridge, Chryston and Bellshill more like this
tabling member printed
Hugh Gaffney remove filter
uin 269105 more like this
answer
answer
is ministerial correction false remove filter
date of answer less than 2019-07-03more like thismore than 2019-07-03
answer text <p>No assessment has been made. NHS Scotland publishes annual reports on the impact of the Scottish Government’s alcohol strategy, a core element of which is minimum unit pricing. However, the Scottish Government will not publish its statutory report on the impact of minimum unit pricing (MUP) until five years post-implementation of the legislation, in 2023. The Government shall monitor the impact of MUP as robust evidence emerges.</p><p><strong> </strong></p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-07-03T13:24:47.117Zmore like thismore than 2019-07-03T13:24:47.117Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4614
label Biography information for Hugh Gaffney more like this
1134036
registered interest false more like this
date less than 2019-06-24more like thismore than 2019-06-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care remove filter
hansard heading NHS: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availablity of (a) critical and (b) short shelf-life medicines in the event of the UK leaving the EU without a deal. more like this
tabling member constituency Coatbridge, Chryston and Bellshill more like this
tabling member printed
Hugh Gaffney remove filter
uin 268516 more like this
answer
answer
is ministerial correction false remove filter
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>The Government fully understands that maintaining access to all medicines and medical products, including critical medicines and short shelf-life products, is vitally important to millions of people in this country. Ensuring unhindered supply of these products remains the Government’s top priority.</p><p> </p><p>As in preparation for 29 March and 12 April, our ‘no deal’ EU Exit contingency plans for 31 October will cover the NHS, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.</p><p>The Department has continued to work closely with the Devolved Administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a ‘no deal’ EU Exit remains a possibility. This work has informed our plans.</p><p>We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a ‘last resort’ to be used only when a supplier’s alternative arrangements encounter difficulties, to ensure uninterrupted supply.</p><p>In the case of medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes, we are working closely with suppliers to make alternative arrangements using airfreight.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>While we never give guarantees, we are confident that, if everyone – including suppliers, freight companies, international partners and the health and care system – does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a no-deal EU Exit.</p>
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
question first answered
less than 2019-07-02T11:33:39.527Zmore like thismore than 2019-07-02T11:33:39.527Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4614
label Biography information for Hugh Gaffney more like this